TITLE

Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM “El Álamo III” retrospective study

AUTHOR(S)
Márquez-Rodas, Iván; Pollán, Marina; Escudero, María José; Ruiz, Amparo; Martín, Miguel; Santaballa, Ana; Martínez del Prado, Purificación; Batista, Norberto; Andrés, Raquel; Antón, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnación; González, Sonia; Seguí, Miguel Angel; Calvo, Lourdes; Lizón, José; Rodríguez Lescure, Álvaro; Ramón y Cajal, Teresa; Llort, Gemma
PUB. DATE
October 2017
SOURCE
PLoS ONE;10/6/2017, Vol. 12 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To determine the frequency of breast cancer (BC) patients with hereditary risk features in a wide retrospective cohort of patients in Spain. Methods: a retrospective analysis was conducted from 10,638 BC patients diagnosed between 1998 and 2001 in the GEICAM registry “El Álamo III”, dividing them into four groups according to modified ESMO and SEOM hereditary cancer risk criteria: Sporadic breast cancer group (R0); Individual risk group (IR); Familial risk group (FR); Individual and familial risk group (IFR) with both individual and familial risk criteria. Results: 7,641 patients were evaluable. Of them, 2,252 patients (29.5%) had at least one hereditary risk criteria, being subclassified in: FR 1.105 (14.5%), IR 970 (12.7%), IFR 177 (2.3%). There was a higher frequency of newly diagnosed metastatic patients in the IR group (5.1% vs 3.2%, p = 0.02). In contrast, in RO were lower proportion of big tumors (> T2) (43.8% vs 47.4%, p = 0.023), nodal involvement (43.4% vs 48.1%, p = 0.004) and lower histological grades (20.9% G3 for the R0 vs 29.8%) when compared to patients with any risk criteria. Conclusions: Almost three out of ten BC patients have at least one hereditary risk cancer feature that would warrant further genetic counseling. Patients with hereditary cancer risk seems to be diagnosed with worse prognosis factors.
ACCESSION #
125540606

 

Related Articles

  • Ovarian Cancer. Morin, Pat J.; Pizer, Ellen S. // Encyclopedic Reference of Cancer;2001, p654 

    The article discusses ovarian cancer, which is a heterogeneous group of malignant tumors derived from the ovary. Ovarian tumors can be designated as epithelial ovarian cancer (EOC), germ cell tumors and stromal tumors. The different kinds of EOC according to histological appearance are described...

  • Acceptability of chemoprevention trials in high-risk subjects. Bonanni, B.; Lazzeroni, M. // Annals of Oncology;Nov2013 Supplement 8, Vol. 24 Issue suppl_8, pviii42 

    The development and current widespread acceptance of clinical trials is one of the major conceptual advances in research medicine introduced during the second half of the 20th century. Despite general agreement on the scientific merits of randomization, many patients and physicians are however...

  • Potential Excess Mortality in BRCA1/2 Mutation Carriers beyond Breast, Ovarian, Prostate, and Pancreatic Cancers, and Melanoma. Mai, Phuong L.; Chatterjee, Nilanjan; Hartge, Patricia; Tucker, Margaret; Brody, Lawrence; Struewing, Jeffery P.; Wacholder, Sholom // PLoS ONE;2009, Vol. 4 Issue 3, p1 

    Background: Although the increase in risk of developing breast, ovarian, and prostate cancer in BRCA1 and BRCA2 mutation carriers has been studied extensively, its impact on mortality is not well quantified. Further, possible effect of BRCA mutations on non-cancer mortality risk has not been...

  • Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Ose, J; Fortner, R T; Schock, H; Peeters, P H; Onland-Moret, N C; Bueno-de-Mesquita, H B; Weiderpass, E; Gram, I T; Overvad, K; Tjonneland, A; Dossus, L; Fournier, A; Baglietto, L; Trichopoulou, A; Benetou, V; Trichopoulos, D; Boeing, H; Masala, G; Krogh, V; Matiello, A // British Journal of Cancer;1/6/2015, Vol. 112 Issue 1, p162 

    Background:Prospective studies on insulin-like growth factor I (IGF-I) and epithelial ovarian cancer (EOC) risk are inconclusive. Data suggest risk associations vary by tumour characteristics.Methods:We conducted a nested case-control study in the European Prospective Investigation into Cancer...

  • Defining breast cancer risk in women.  // Australian Nursing Journal;Dec97/Jan98, Vol. 5 Issue 6, p37 

    Discusses the development of a method of identifying women at high risk of breast and ovarian cancers. Importance of family history, age of onset and ethnicity in identifying cancer; Examining the BRCA1 gene; Role of genetics in breast cancer.

  • Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Derks-Smeets, I.A.P.; Gietel-Habets, J.J.G.; Tibben, A.; Tjan-Heijnen, V.C.G.; Meijer-Hoogeveen, M.; Geraedts, J.P.M.; van Golde, R.; Gomez-Garcia, E.; van den Bogaart, E.; van Hooijdonk, M.; de Die-Smulders, C.E.M.; van Osch, L.A.D.M. // Human Reproduction;May2014, Vol. 29 Issue 5, p1103 

    STUDY QUESTION How do couples with a BRCA1/2 mutation decide on preimplantation genetic diagnosis (PGD) and prenatal diagnosis (PND) for hereditary breast and ovarian cancer syndrome (HBOC)? SUMMARY ANSWER BRCA couples primarily classify PGD and/or PND as reproductive options based on the...

  • EFFECT OF HORMONE ENVIRONMENT ON UNSCHEDULED DNA SYNTHESIS IN WOMEN AT HIGH RISK VERSUS NORMAL RISK FOR BREAST CANCER. Eggert, Julie; Larcom, Lyndon // Oncology Nursing Forum;Jan2007, Vol. 34 Issue 1, p228 

    Though more is known about the relationship of hormones and breast cancer, there are still unanswered questions of the relationship of hormones have with a malignancy in the female breast. More information would galvanize the tool kit of information available for oncology nurses to share with...

  • Beyond BRCA 1/2: Detecting other genes associated with breast cancer. McKnight, Whitney // Hem/Onc Today;4/10/2011, Vol. 12 Issue 7, p15 

    The article focuses on a paper presented by Mark E. Robson at the 28th Annual Miami Breast Cancer Conference which argued that testing for other breast cancer predisposition syndromes may help medical personnel accurately determine a patient's level of risk when initial tests do not indicate a...

  • A New Way to Look at Lumps.  // Health (Time Inc. Health);Apr2000, Vol. 14 Issue 3, p26 

    Focuses on a study conducted by Vanderbilt University researchers which identified a molecular warning sign that may determine the risk for women to develop a benign breast disease called epithelial hyperplasia. Methods and subjects used in the study; Findings of the study.

  • Early diagnosis of breast cancer key to survival. Wagstaff, Donna // South County Journal;10/5/2011, Vol. 56 Issue 40, pB2 

    The article discusses the American Cancer Society's guidelines for early detection of breast cancer and some of the common risk factors of the disease.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics